Table 3.

Antimicrobial susceptibility of bacterial pathogens related to UTI and RUTI (sample size = 809) used in the second stage analysis. The name in the parentheses represents the label of the factor used in the machine learning models. Data are presented with number (percentage). Abbreviations: UTI, urinary tract infection; RUTI, recurrent urinary tract infection. S, susceptible; I, intermediate; R, resistant.

Antimicrobial susceptibility	UTI (n = 697)	RUTI (n = 112)	P value
Ampicillin (Anti4)	n = 638	n = 98	0.2392
S	126 (20)	13 (13)
I	3 (0)	0 (0)
R	509 (80)	85 (87)
Amoxicillin/clavulanic acid (Anti2)	n = 454	n = 69	0.0838
S	277 (61)	35 (50)
I	52 (11)	6 (9)
R	125 (28)	28 (41)
Cefazolin (Anti5)	n = 638	n = 98	0.0003
S	407 (64)	44 (45)
I	18 (3)	1 (1)
R	213 (33)	53 (54)
Cefuroxime (Anti14)	n = 628	n = 96	0.0058
S	430 (68)	50 (52)
I	22 (4)	4 (4)
R	176 (28)	42 (44)
Cefmetazole (Anti8)	n = 450	n = 68	0.4653
S	350 (77)	49 (72)
I	16 (4)	2 (3)
R	84 (19)	17 (25)
Cefixime (Anti7)	n = 637	n = 98	0.0004
S	435 (68)	45 (46)
I	5 (1)	1 (1)
R	197 (31)	52 (53)
Ceftriaxone (Anti13)	n = 451	n = 68	0.0897
S	311 (69)	38 (56)
I	62 (14)	12 (18)
R	78 (17)	18 (26)
Cefpirome (Anti11)	n = 637	n = 98	0.0807
S	559 (88)	78 (80)
I	14 (2)	3 (3)
R	64 (10)	17 (17)
Ertapenem (Anti19)	n = 623	n = 95	0.1509
S	621 (100)	93 (98)
I	0 (0)	0 (0)
R	2 (0)	2 (2)
Gentamicin (Anti23)	n = 636	n = 98	0.0994
S	420 (66)	54 (55)
I	13 (2)	2 (2)
R	203 (32)	42 (43)
Amikacin (Anti1)	n = 634	n = 97	0.3417
S	622 (98)	94 (97)
I	8 (1)	1 (1)
R	4 (1)	2 (2)
Levofloxacin (Anti25)	n = 636	n = 98	0.0010
S	403 (63)	43 (44)
I	6 (1)	2 (2)
R	227 (36)	53 (54)
Co-trimoxazole (Anti18)	n = 625	n = 95	0.0840
S	281 (45)	33 (35)
I	7 (1)	0 (0)
R	337 (54)	62 (65)